Yes

Corticosteroid, Topical

Short-term relief of inflammation of moderate to severe corticosteroid-responsive dermatosis (very high potency topical corticosteroid)

C

Known hypersensitivity to clobetasol; viral, fungal, or tubercular skin lesions

Adrenal suppression can occur if used for >14 days. Topical foam is not for use in children <12 years of age. Topical foam should not be used with occlusive dressings unless directed by healthcare provider.

1% to 10%:

Dermatologic: Itching, erythema,

Local: Burning, dryness, irritation, papular rashes

<1%: Hypertrichosis, acneiform eruptions, maceration of skin, skin atrophy, striae, hypopigmentation, perioral dermatitis, miliaria, eczema (foam), skin hypertrophy (foam)

No data reported

Stimulates the synthesis of enzymes needed to decrease inflammation, suppress mitotic activity, and cause vasoconstriction

Absorption: Percutaneous absorption variable and dependent upon many factors including vehicle used, integrity of epidermis, dose, and use of occlusive dressings

Metabolism: Remains to be defined

Elimination: In urine and bile

Adults: Topical:

Foam: Scalp: Apply to affected scalp twice daily for up to 2 weeks ( less than or equal to 50 g/week)

None reported

None reported

No information available to require special precautions

No effects or complications reported

A thin film of cream or ointment is effective; do not overuse; do not use tight-fitting diapers or plastic pants on children being treated in the diaper area; use only as prescribed and for no longer than the period prescribed; apply sparingly in light film; rub in lightly; avoid contact with eyes; notify physician if condition being treated persists or worsens; to apply foam, hold can upside down and apply directly to scalp; gently massage foam into affected area until foam disappears

For external use only; do not use on open wounds; apply sparingly to occlusive dressings; should not be used in the presence of open or weeping lesions; do not use occlusive dressings with foam unless directed by healthcare provider

Cream, as propionate: 0.05% (15 g, 30 g, 45 g)

Cream, as propionate, in emollient base: 0.05% (15 g, 30 g, 60 g)

Gel, as propionate: 0.05% (15 g, 30 g, 45 g)

Ointment, topical, as propionate: 0.05% (15 g, 30 g, 45 g)

Scalp application, as propionate: 0.05% (25 mL, 50 mL)

Foam (Olux™): 0.05% (100 g)